$7.620
+0.226 (+2.97%)收盤時
NLSP 同業比較
In the context of the broader market, NLSP competes directly with industry leaders such as ONCO and KALA. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, NLSP's gross margin of N/A stands against ONCO's 25.13% and KALA's N/A. Such benchmarking helps identify whether NLS Pharmaceutics AG is trading at a premium or discount relative to its financial performance.
Financials
No data
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。